Abstract
To assess the role of each envelope-associated protein (i.e., ORFs 2–6 products) of type 2 PRRSV in cross neutralization mediated by antibody, chimeric mutants were generated by replacing ORFs of a VR2332-based infectious clone with those of JA142, SDSU73, PRRS124, or 2M11715 that are genetically and antigenically distinct from VR2332 and two-way neutralization assays were performed on those mutants using VR2332, JA142, SDSU73, or PRRS124 antisera. All ORF 5-replaced mutants showed increased susceptibility or resistance against homologous or heterologous antisera, respectively, in comparison to that of the donor strains, but failed to achieve a complete reversion of cross neutralization. In contrast, substitution of ORFs 3–6 completely reversed the susceptibility of the virus to neutralization by antibody. Changes in ORFs 3, 5, and 6 were additively responsible for reversion of the susceptibility, suggesting that the genetic similarity of these ORFs should be considered for better cross neutralization between two different type 2 PRRS viruses.
Similar content being viewed by others
References
C. Prieto, J.M. Castro, Theriogenology 63, 1–16 (2005). doi:10.1016/j.theriogenology.2004.03.018
E. Albina, Vet. Microbiol. 55, 309–316 (1997). doi:10.1016/S0378-1135(96)01322-3
J.G. Cho, S.A. Dee, Theriogenology 66, 655–662 (2006). doi:10.1016/j.theriogenology.2006.04.024
E.J. Neumann, J.B. Kliebenstein, C.D. Johnson, J.W. Mabry, E.J. Bush, A.H. Seitzinger et al., J. Am. Vet. Med. Assoc. 227, 385–392 (2005). doi:10.2460/javma.2005.227.385
A.A. de Vries, M.C. Horzinek, P.J. Rottier, R.J. de Groot, Semin. Virol. 8, 33–47 (1997). doi:10.1006/smvy.1997.0104
D. Cavanagh, Arch. Virol. 142, 629–633 (1997)
A.E. Gorbalenya, L. Enjuanes, J. Ziebuhr, E.J. Snijder, Virus Res. 117, 17–37 (2006). doi:10.1016/j.virusres.2006.01.017
G. Wensvoort, C. Terpstra, J.M. Pol, E.A. ter Laak, M. Bloemraad, E.P. de Kluyver et al., Vet. Q. 13, 121–130 (1991)
D.A. Benfield, E. Nelson, J.E. Collins, L. Harris, S.M. Goyal, D. Robison et al., J. Vet. Diagn. Invest. 4, 127–133 (1992)
S. Dea, C.A. Gagnon, H. Mardassi, G. Milane, J. Clin. Microbiol. 34, 1488–1493 (1996)
G. Wensvoort, E.P. de Kluyver, E.A. Luijtze, A. den Besten, L. Harris, J.E. Collins et al., J. Vet. Diagn. Invest. 4, 134–138 (1992)
R. Magar, R. Larochelle, S. Dea, C.A. Gagnon, E.A. Nelson, J. Christopher-Hennings et al., Can. J. Vet. Res. 59, 232–234 (1995)
S. Dea, C.A. Gagnon, H. Mardassi, B. Pirzadeh, D. Rogan, Arch. Virol. 145, 659–688 (2000). doi:10.1007/s007050050662
R. Allende, T.L. Lewis, Z. Lu, D.L. Rock, G.F. Kutish, A. Ali et al., J. Gen. Virol. 80, 307–315 (1999)
E.J. Snijder, J.J. Meulenberg, J. Gen. Virol. 79, 961–979 (1998)
E.H. Wissink, M.V. Kroese, H.A. van Wijk, F.A. Rijsewijk, J.J. Meulenberg, P.J. Rottier, J. Virol. 79, 12495–12506 (2005). doi:10.1128/JVI.79.19.12495-12506.2005
W.H. Wu, Y. Fang, R. Farwell, M. Steffen-Bien, R.R. Rowland, J. Christopher-Hennings et al., Virology 287, 183–191 (2001). doi:10.1006/viro.2001.1034
H. Mardassi, B. Massie, S. Dea, Virology 221, 98–112 (1996). doi:10.1006/viro.1996.0356
P. Gonin, B. Pirzadeh, C.A. Gagnon, S. Dea, J. Vet. Diagn. Invest. 11, 20–26 (1999)
E. Weiland, M. Wieczorek-Krohmer, D. Kohl, K.K. Conzelmann, F. Weiland, Vet. Microbiol. 66, 171–186 (1999). doi:10.1016/S0378-1135(99)00006-1
B. Pirzadeh, S. Dea, J. Gen. Virol. 78, 1867–1873 (1997)
V.G. Andreyev, R.D. Wesley, W.L. Mengeling, A.C. Vorwald, K.M. Lager, Arch. Virol. 142, 993–1001 (1997). doi:10.1007/s007050050134
S. Pesch, C. Meyer, V.F. Ohlinger, Vet. Microbiol. 107, 31–48 (2005). doi:10.1016/j.vetmic.2005.01.028
G. Labarque, K.V. Reeth, H. Nauwynck, C. Drexler, S. Van Gucht, M. Pensaert, Vaccine 22, 4183–4190 (2004). doi:10.1016/j.vaccine.2004.05.008
W.L. Mengeling, K.M. Lager, A.C. Vorwald, Am. J. Vet. Res. 59, 1540–1544 (1998)
K.-J. Yoon, C.C. Chang, J.J. Zimmerman, K. Harmon, Adv. Exp. Med. Biol. 494, 25–30 (2001)
Y. Jiang, S. Xiao, L. Fang, X. Yu, Y. Song, C. Niu et al., Vaccine 24, 2869–2879 (2006). doi:10.1016/j.vaccine.2005.12.049
W. Jiang, P. Jiang, Y. Li, J. Tang, X. Wang, S. Ma, Vet. Immunol. Immunopathol. 113, 169–180 (2006). doi:10.1016/j.vetimm.2006.05.001
R. Wieringa, A.A. de Vries, J. van der Meulen, G.J. Godeke, J.J. Onderwater, H. van Tol et al., J. Virol. 78, 13019–13027 (2004). doi:10.1128/JVI.78.23.13019-13027.2004
J.C. Dobbe, Y. van der Meer, W.J. Spaan, E.J. Snijder, Virology 288, 283–294 (2001). doi:10.1006/viro.2001.1074
M.H. Verheije, T.J. Welting, H.T. Jansen, P.J. Rottier, J.J. Meulenberg, Virology 303, 364–373 (2002). doi:10.1006/viro.2002.1711
H.S. Nielsen, G. Liu, J. Nielsen, M.B. Oleksiewicz, A. Botner, T. Storgaard et al., J. Virol. 77, 3702–3711 (2003). doi:10.1128/JVI.77.6.3702-3711.2003
W. Johnson, M. Roof, E. Vaughn, J. Christopher-Hennings, C.R. Johnson, M.P. Murtaugh, Vet. Immunol. Immunopathol. 102, 233–247 (2004). doi:10.1016/j.vetimm.2004.09.010
W.-I. Kim, D.-S. Lee, W. Johnson, M. Roof, S.-H. Cha, K.-J. Yoon, Vet. Microbiol. 123, 1–14 (2007). doi:10.1016/j.vetmic.2007.03.007
H.S. Kim, J. Kwang, I.J. Yoon, H.S. Joo, M.L. Frey, Arch. Virol. 133, 477–483 (1993). doi:10.1007/BF01313785
K. Miyazaki, M. Takenouchi, Biotechniques 33(1033–1034), 1036–1038 (2002)
H.M. Truong, Z. Lu, G.F. Kutish, J. Galeota, F.A. Osorio, A.K. Pattnaik, Virology 325, 308–319 (2004). doi:10.1016/j.virol.2004.04.046
A. Greig, Arch. Virol. 47, 287–289 (1975). doi:10.1007/BF01317816
L.J. Reed, H. Muench, Am. J. Hyg. 27, 493–497 (1938)
Dawson B, Trapp RG, in Basic & Clinical Biostatistics (McGraw-Hill Professional, New York, 2004), pp. 162–189
S. Kumar, K. Tamura, I.B. Jakobsen, M. Nei, Bioinformatics 17, 1244–1245 (2001). doi:10.1093/bioinformatics/17.12.1244
P.G. Plagemann, Vet. Immunol. Immunopathol. 102, 263–275 (2004). doi:10.1016/j.vetimm.2004.09.011
P.G. Plagemann, R.R. Rowland, K.S. Faaberg, Arch. Virol. 147, 2327–2347 (2002). doi:10.1007/s00705-002-0887-2
Y.J. Zhou, T.Q. An, Y.X. He, J.X. Liu, H.J. Qiu, Y.F. Wang et al., Virus Res. 118, 98–104 (2006). doi:10.1016/j.virusres.2005.11.019
J. Plana Duran, I. Climent, J. Sarraseca, A. Urniza, E. Cortes, C. Vela et al., Virus Genes 14, 19–29 (1997). doi:10.1023/A:1007931322271
S.M. Cancel-Tirado, R.B. Evans, K.J. Yoon, Vet. Immunol. Immunopathol. 102, 249–262 (2004). doi:10.1016/j.vetimm.2004.09.017
J.J. Meulenberg, A. Petersen-den Besten, E.P. De Kluyver, R.J. Moormann, W.M. Schaaper, G. Wensvoort, Virology 206, 155–163 (1995). doi:10.1016/S0042-6822(95)80030-1
A.P. van Nieuwstadt, J.J. Meulenberg, A. van Essen-Zanbergen, A. Petersen-den Besten, R.J. Bende, R.J. Moormann et al., J. Virol. 70, 4767–4772 (1996)
P. Gonin, H. Mardassi, C.A. Gagnon, B. Massie, S. Dea, Arch. Virol. 143, 1927–1940 (1998). doi:10.1007/s007050050430
H. Mardassi, P. Gonin, C.A. Gagnon, B. Massie, S. Dea, J. Virol. 72, 6298–6306 (1998)
R. Wieringa, A.A. de Vries, M.J. Raamsman, P.J. Rottier, J. Virol. 76, 10829–10840 (2002). doi:10.1128/JVI.76.21.10829-10840.2002
F. Zhang, M. Yu, E. Weiland, C. Morrissy, N. Zhang, H. Westbury et al., Arch. Virol. 151, 37–54 (2006). doi:10.1007/s00705-005-0623-9
J.M. Windisch, R. Schneider, R. Stark, E. Weiland, G. Meyers, H.J. Thiel, J. Virol. 70, 352–358 (1996)
H. Ito, S. Watanabe, A. Takada, Y. Kawaoka, J. Virol. 75, 1576–1580 (2001). doi:10.1128/JVI.75.3.1576-1580.2001
J.J. Meulenberg, A.P. van Nieuwstadt, A. van Essen-Zandbergen, J.P. Langeveld, J. Virol. 71, 6061–6067 (1997)
I.H. Ansari, B. Kwon, F.A. Osorio, A.K. Pattnaik, J. Virol. 80, 3994–4004 (2006). doi:10.1128/JVI.80.8.3994-4004.2006
K.S. Faaberg, J.D. Hocker, M.M. Erdman, D.L. Harris, E.A. Nelson, M. Torremorell et al., Viral Immunol. 19, 294–304 (2006). doi:10.1089/vim.2006.19.294
M. de Lima, A.K. Pattnaik, E.F. Flores, F.A. Osorio, Virology 353, 410–421 (2006). doi:10.1016/j.virol.2006.05.036
Acknowledgments
The authors wish to thank Ms. Christine Meraz for excellent assistance in manuscript preparation. Dr. Fernando Osorio at the University of Nebraska (Lincoln, NE) and Dr. Kay Faaberg at the University of Minnesota (St. Paul, MN) are acknowledged for providing antisera and the VR2332 infectious clone, respectively, which were extremely valuable to this study. The study was supported in part by funding from the United States Department of Agriculture Formula Grant, Iowa Livestock Health Advisory Council, and the Iowa Pork Producers Association.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kim, WI., Yoon, KJ. Molecular assessment of the role of envelope-associated structural proteins in cross neutralization among different PRRS viruses. Virus Genes 37, 380–391 (2008). https://doi.org/10.1007/s11262-008-0278-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11262-008-0278-1